tiprankstipranks
Advertisement
Advertisement

AU:CMB Stock Latest News

Cambium Bio Wins FDA Backing for Single Pivotal Trial for Elate Ocular
Company AnnouncementsCambium Bio Wins FDA Backing for Single Pivotal Trial for Elate Ocular
11d ago
CMB
Cambium Bio Director Increases Stake Through Share Placement
PremiumCompany Announcements
Cambium Bio Director Increases Stake Through Share Placement
1M ago
CMB
Cambium Bio Issues New Shares Under Cleansing Notice, Affirms Regulatory Compliance
PremiumCompany Announcements
Cambium Bio Issues New Shares Under Cleansing Notice, Affirms Regulatory Compliance
2M ago
CMB
Cambium Bio Seeks ASX Quotation for 4.36 Million New Shares
PremiumCompany Announcements
Cambium Bio Seeks ASX Quotation for 4.36 Million New Shares
2M ago
CMB
Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions
PremiumCompany Announcements
Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions
2M ago
CMB
Cambium Bio Narrows Half-Year Loss and Turns NTAs Positive as Revenue Grows
PremiumCompany AnnouncementsCambium Bio Narrows Half-Year Loss and Turns NTAs Positive as Revenue Grows
2M ago
CMB
Cambium Bio Plans Significant Share Placement to Raise Equity
Premium
Company Announcements
Cambium Bio Plans Significant Share Placement to Raise Equity
3M ago
CMB
Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control
Premium
Company Announcements
Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control
3M ago
CMB
Cambium Bio Secures Funding and Advances Toward Phase 3 Trials for Elate Ocular
PremiumCompany Announcements
Cambium Bio Secures Funding and Advances Toward Phase 3 Trials for Elate Ocular
3M ago
CMB
Cambium Bio Plans Share Placement to Raise Fresh Capital
PremiumCompany Announcements
Cambium Bio Plans Share Placement to Raise Fresh Capital
3M ago
CMB
Cambium Bio Raises A$2.4m at Premium from Major Shareholder to Fund Phase 3 Dry Eye Trials
PremiumCompany Announcements
Cambium Bio Raises A$2.4m at Premium from Major Shareholder to Fund Phase 3 Dry Eye Trials
3M ago
CMB
Cambium Bio Advances with Strategic Partnerships and R&D Incentives
PremiumCompany Announcements
Cambium Bio Advances with Strategic Partnerships and R&D Incentives
6M ago
CMB
Cambium Bio Corrects Director’s Interest Notice Date
PremiumCompany AnnouncementsCambium Bio Corrects Director’s Interest Notice Date
6M ago
CMB
Regeneus Ltd. Director Increases Stake with New Share Acquisition
Premium
Company Announcements
Regeneus Ltd. Director Increases Stake with New Share Acquisition
6M ago
CMB
Regeneus Director Increases Stake with New Share Acquisition
Premium
Company Announcements
Regeneus Director Increases Stake with New Share Acquisition
6M ago
CMB
Cambium Bio Limited Issues New Shares
PremiumCompany Announcements
Cambium Bio Limited Issues New Shares
7M ago
CMB
Cambium Bio Limited Announces Quotation of New Securities
PremiumCompany Announcements
Cambium Bio Limited Announces Quotation of New Securities
7M ago
CMB
Cambium Bio Limited Reports AGM Results with Notable ‘First Strike’
PremiumCompany Announcements
Cambium Bio Limited Reports AGM Results with Notable ‘First Strike’
7M ago
CMB
Cambium Bio Limited Highlights Regenerative Medicine Advances at 2025 AGM
PremiumCompany Announcements
Cambium Bio Limited Highlights Regenerative Medicine Advances at 2025 AGM
7M ago
CMB
Cambium Bio Partners with Locus Cell for Global Production of Elate Ocular® ABI
PremiumCompany AnnouncementsCambium Bio Partners with Locus Cell for Global Production of Elate Ocular® ABI
7M ago
CMB
Cambium Bio Limited Announces Proposed Securities Issue
Premium
Company Announcements
Cambium Bio Limited Announces Proposed Securities Issue
8M ago
CMB
Cambium Bio Limited Announces 2025 AGM Details
Premium
Company Announcements
Cambium Bio Limited Announces 2025 AGM Details
8M ago
CMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >